SlideShare una empresa de Scribd logo

Enfermedad del higado graso no alcoholico

•Descargar como PPTX, PDF•
•
Jorge Bustos
Jorge Bustos
1 de 26
ENFERMEDAD DEL HIGADO GRASO NO ALCOHOLICO Jorge Arturo Bustos Martinez Residente de segundo año medicina interna Universidad del Norte
Definición Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Definición NAFLD termino introducido por primera vez en 1980 por Ludwig Et. Al. clínica Mayo. Tradicionalmente se incluyen dos condiciones distintas: Hígado graso no alcohólico: superior al 5 al 10% del peso total. Esteatohepatitis: esteatosis, inflamación lobular, lesión del hepatocito y/o fibrosis. Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Epidemiologia Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Epidemiologia Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Factores Etiológicos y Asociaciones MarcinKrawczyk Et. Al. Nonalcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 24 (2010) 695–708
Factores Etiológicos y Asociaciones Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Factores Etiológicos y Asociaciones Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Factores Etiológicos y Asociaciones Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Factores Etiológicos y Asociaciones John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
Fisiopatología Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Fisiopatología Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
Fisiopatología John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
Fisiopatología Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Fisiopatología John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
Fisiopatología John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
Fisiopatología Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Diagnostico Mayoría clínicamente asintomáticos: Dolor en cuadrante superior derecho Nauseas Otros síntomas inespecíficos. NASH a Cirrosis: Telangiectasias Eritema palmar Caputmedusae Etc. Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
Diagnostico SteatoTest: propuesto por Poynard Et. Al. VPP: 63% VPN: 93% ALT, alfa 2 macroglobulina, Apolipoproteina, Haptoglobina, BT, GGT, Colesterol, Trigliceridos, Glucosa, Edad, Sexo e IMC. FibroTest: Alfa 2 macroglobulina, Apolipoproteina, BT, GGT y ALT. VPP: 73% VPN: 90% Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
Diagnostico Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
Diagnostico MarcinKrawczyk Et. Al. Nonalcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 24 (2010) 695–708
Diagnostico MarcinKrawczyk Et. Al. Nonalcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 24 (2010) 695–708
Diagnostico John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
Tratamiento Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
Tratamiento John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
Gracias

Recomendados

La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...
La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...
La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...CIESS-UNIVPM
 
Natural history NAFLD/NASH from Chronic Liver Disease Foundation
Natural history NAFLD/NASH from Chronic Liver Disease FoundationNatural history NAFLD/NASH from Chronic Liver Disease Foundation
Natural history NAFLD/NASH from Chronic Liver Disease FoundationNAFLD
 
Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease(NAFLD)Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease(NAFLD)Bhavin Mandowara
 
Ueda2015 nafld, diabetes heart_dr.abdel-khalek
Ueda2015 nafld, diabetes heart_dr.abdel-khalekUeda2015 nafld, diabetes heart_dr.abdel-khalek
Ueda2015 nafld, diabetes heart_dr.abdel-khalekueda2015
 
Non Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar Slides
Non Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar SlidesNon Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar Slides
Non Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar SlidesCovance
 
GIT J Club: NAFLD.
GIT J Club: NAFLD.GIT J Club: NAFLD.
GIT J Club: NAFLD.Shaikhani.
 
Non alcoholic fatty liver disease
Non alcoholic fatty liver diseaseNon alcoholic fatty liver disease
Non alcoholic fatty liver diseaseakifab93
 
Non Alcoholic Steatohepatitis
Non Alcoholic SteatohepatitisNon Alcoholic Steatohepatitis
Non Alcoholic SteatohepatitisElmuhtady Said FRCP FEBGH
 

Recomendados

La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...
La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...
La steatosi epatica quale fattore di rischio epatico e cardiovascolare: fatto...CIESS-UNIVPM
 
Natural history NAFLD/NASH from Chronic Liver Disease Foundation
Natural history NAFLD/NASH from Chronic Liver Disease FoundationNatural history NAFLD/NASH from Chronic Liver Disease Foundation
Natural history NAFLD/NASH from Chronic Liver Disease FoundationNAFLD
 
Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease(NAFLD)Non alcoholic fatty liver disease(NAFLD)
Non alcoholic fatty liver disease(NAFLD)Bhavin Mandowara
 
Ueda2015 nafld, diabetes heart_dr.abdel-khalek
Ueda2015 nafld, diabetes heart_dr.abdel-khalekUeda2015 nafld, diabetes heart_dr.abdel-khalek
Ueda2015 nafld, diabetes heart_dr.abdel-khalekueda2015
 
Non Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar Slides
Non Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar SlidesNon Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar Slides
Non Invasive Biomarkers in NASH (non-alcoholic steatohepatitis) Webinar SlidesCovance
 
GIT J Club: NAFLD.
GIT J Club: NAFLD.GIT J Club: NAFLD.
GIT J Club: NAFLD.Shaikhani.
 
Non alcoholic fatty liver disease
Non alcoholic fatty liver diseaseNon alcoholic fatty liver disease
Non alcoholic fatty liver diseaseakifab93
 
Non Alcoholic Steatohepatitis
Non Alcoholic SteatohepatitisNon Alcoholic Steatohepatitis
Non Alcoholic SteatohepatitisElmuhtady Said FRCP FEBGH
 
Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.
Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.
Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.KETAN VAGHOLKAR
 
Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?philaberry
 
NAFLD, NASH
NAFLD, NASHNAFLD, NASH
NAFLD, NASHShatdal Chaudhary
 
Evidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver diseaseEvidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver diseaseJayastu Senapati
 
NAFLD
NAFLDNAFLD
NAFLDkatejohnpunag
 
Acute pancreatitis nejm 2006
Acute pancreatitis nejm 2006Acute pancreatitis nejm 2006
Acute pancreatitis nejm 2006Andrés Menéndez Rojas
 
Nonalcoholic fatty liver disease in children and adolescents
Nonalcoholic fatty liver disease in children and adolescentsNonalcoholic fatty liver disease in children and adolescents
Nonalcoholic fatty liver disease in children and adolescentsjoannayeh
 
Fatty Liver Disease - Kuwait
Fatty Liver Disease - KuwaitFatty Liver Disease - Kuwait
Fatty Liver Disease - KuwaitNeil Theise
 
NON ALCOHOLIC FATTY LIVER DISEASE
NON ALCOHOLIC FATTY LIVER DISEASENON ALCOHOLIC FATTY LIVER DISEASE
NON ALCOHOLIC FATTY LIVER DISEASEDr. Haritha Sridhar
 
Non alcoholic steatohepatitis copy
Non alcoholic steatohepatitis copyNon alcoholic steatohepatitis copy
Non alcoholic steatohepatitis copyKeshri Yadav
 
Nonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) ReviewNonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) Reviewmfabzak
 
NAFLD in Children
NAFLD in ChildrenNAFLD in Children
NAFLD in ChildrenCSN Vittal
 
Nafld
NafldNafld
NafldRajesh Mandal
 
Nafld
NafldNafld
Nafldakifab93
 
Autoimmune Pancreatitis
Autoimmune PancreatitisAutoimmune Pancreatitis
Autoimmune PancreatitisApollo Hospitals
 
Non alcoholic fatty liver disease
Non alcoholic fatty liver disease Non alcoholic fatty liver disease
Non alcoholic fatty liver disease Akuffo Quarde
 
Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Chien-Wei Su
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitisAhmed Ghany
 
Rahimi management of nafld
Rahimi management of nafldRahimi management of nafld
Rahimi management of nafldPoursinaHakim
 
Talk : NAFLD by Dr. S.P. Singh
Talk : NAFLD by Dr. S.P. SinghTalk : NAFLD by Dr. S.P. Singh
Talk : NAFLD by Dr. S.P. SinghSanjeev Kumar
 
Update on NAFLD NASH.pptx
Update on NAFLD NASH.pptxUpdate on NAFLD NASH.pptx
Update on NAFLD NASH.pptxakankshagupta109892
 
MAFLD, a new name of an old disease
MAFLD, a new name of an old diseaseMAFLD, a new name of an old disease
MAFLD, a new name of an old diseaseEl-Sayed Tharwa
 

Más contenido relacionado

La actualidad más candente

Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.
Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.
Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.KETAN VAGHOLKAR
 
Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?philaberry
 
Evidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver diseaseEvidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver diseaseJayastu Senapati
 
Nonalcoholic fatty liver disease in children and adolescents
Nonalcoholic fatty liver disease in children and adolescentsNonalcoholic fatty liver disease in children and adolescents
Nonalcoholic fatty liver disease in children and adolescentsjoannayeh
 
Fatty Liver Disease - Kuwait
Fatty Liver Disease - KuwaitFatty Liver Disease - Kuwait
Fatty Liver Disease - KuwaitNeil Theise
 
NON ALCOHOLIC FATTY LIVER DISEASE
NON ALCOHOLIC FATTY LIVER DISEASENON ALCOHOLIC FATTY LIVER DISEASE
NON ALCOHOLIC FATTY LIVER DISEASEDr. Haritha Sridhar
 
Non alcoholic steatohepatitis copy
Non alcoholic steatohepatitis copyNon alcoholic steatohepatitis copy
Non alcoholic steatohepatitis copyKeshri Yadav
 
Nonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) ReviewNonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) Reviewmfabzak
 
NAFLD in Children
NAFLD in ChildrenNAFLD in Children
NAFLD in ChildrenCSN Vittal
 
Non alcoholic fatty liver disease
Non alcoholic fatty liver disease Non alcoholic fatty liver disease
Non alcoholic fatty liver disease Akuffo Quarde
 
Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Chien-Wei Su
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitisAhmed Ghany
 
Rahimi management of nafld
Rahimi management of nafldRahimi management of nafld
Rahimi management of nafldPoursinaHakim
 
Talk : NAFLD by Dr. S.P. Singh
Talk : NAFLD by Dr. S.P. SinghTalk : NAFLD by Dr. S.P. Singh
Talk : NAFLD by Dr. S.P. SinghSanjeev Kumar
 

La actualidad más candente (20)

Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.
Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.
Non Alcoholic Fatty Liver Disease: A New Urban Epidemic.
 
Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?Non alcoholic fatty liver disease: what can we do about it?
Non alcoholic fatty liver disease: what can we do about it?
 
NAFLD, NASH
NAFLD, NASHNAFLD, NASH
NAFLD, NASH
 
Evidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver diseaseEvidence based management of Non Alcoholic fatty liver disease
Evidence based management of Non Alcoholic fatty liver disease
 
NAFLD
NAFLDNAFLD
NAFLD
 
Acute pancreatitis nejm 2006
Acute pancreatitis nejm 2006Acute pancreatitis nejm 2006
Acute pancreatitis nejm 2006
 
Nonalcoholic fatty liver disease in children and adolescents
Nonalcoholic fatty liver disease in children and adolescentsNonalcoholic fatty liver disease in children and adolescents
Nonalcoholic fatty liver disease in children and adolescents
 
Fatty Liver Disease - Kuwait
Fatty Liver Disease - KuwaitFatty Liver Disease - Kuwait
Fatty Liver Disease - Kuwait
 
NON ALCOHOLIC FATTY LIVER DISEASE
NON ALCOHOLIC FATTY LIVER DISEASENON ALCOHOLIC FATTY LIVER DISEASE
NON ALCOHOLIC FATTY LIVER DISEASE
 
Non alcoholic steatohepatitis copy
Non alcoholic steatohepatitis copyNon alcoholic steatohepatitis copy
Non alcoholic steatohepatitis copy
 
Nonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) ReviewNonalcoholic Steatohepatitis (NASH) Review
Nonalcoholic Steatohepatitis (NASH) Review
 
NAFLD in Children
NAFLD in ChildrenNAFLD in Children
NAFLD in Children
 
Nafld
NafldNafld
Nafld
 
Nafld
NafldNafld
Nafld
 
Autoimmune Pancreatitis
Autoimmune PancreatitisAutoimmune Pancreatitis
Autoimmune Pancreatitis
 
Non alcoholic fatty liver disease
Non alcoholic fatty liver disease Non alcoholic fatty liver disease
Non alcoholic fatty liver disease
 
Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitis
 
Rahimi management of nafld
Rahimi management of nafldRahimi management of nafld
Rahimi management of nafld
 
Talk : NAFLD by Dr. S.P. Singh
Talk : NAFLD by Dr. S.P. SinghTalk : NAFLD by Dr. S.P. Singh
Talk : NAFLD by Dr. S.P. Singh
 

Similar a Enfermedad del higado graso no alcoholico

MAFLD, a new name of an old disease
MAFLD, a new name of an old diseaseMAFLD, a new name of an old disease
MAFLD, a new name of an old diseaseEl-Sayed Tharwa
 
Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...
Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...
Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...CrimsonGastroenterology
 
Diabetes presentation nosscr 112011 san antonio 2
Diabetes presentation nosscr 112011 san antonio 2Diabetes presentation nosscr 112011 san antonio 2
Diabetes presentation nosscr 112011 san antonio 2Law Firm
 
Common digestive concerns
Common digestive concernsCommon digestive concerns
Common digestive concernsEllen Wong
 
Common liver Disease in Primary Care Setting
Common liver Disease in Primary Care SettingCommon liver Disease in Primary Care Setting
Common liver Disease in Primary Care SettingChernHaoChong
 
Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)Sariu Ali
 
Diabetes and gut
Diabetes and gut Diabetes and gut
Diabetes and gut Usama Ragab
 
Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019
Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019
Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019hivlifeinfo
 
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity SurgeryResolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity SurgeryGeorge S. Ferzli
 
WWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HSWWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HSHillary Sullivan, DTR
 
Is There a Role for Surgery in the Treatment of Diabetes
Is There a Role for Surgery in the Treatment of DiabetesIs There a Role for Surgery in the Treatment of Diabetes
Is There a Role for Surgery in the Treatment of DiabetesGeorge S. Ferzli
 
Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...
Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...
Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...CrimsonGastroenterology
 

Similar a Enfermedad del higado graso no alcoholico (20)

Update on NAFLD NASH.pptx
Update on NAFLD NASH.pptxUpdate on NAFLD NASH.pptx
Update on NAFLD NASH.pptx
 
MAFLD, a new name of an old disease
MAFLD, a new name of an old diseaseMAFLD, a new name of an old disease
MAFLD, a new name of an old disease
 
NAFLD-Metabolic Syndrome- THE LINK
NAFLD-Metabolic Syndrome- THE LINKNAFLD-Metabolic Syndrome- THE LINK
NAFLD-Metabolic Syndrome- THE LINK
 
NAFLD
NAFLDNAFLD
NAFLD
 
Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...
Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...
Crimson Publishers: Dietary Supplements as a Possible Trigger of Autoimmune H...
 
DILI
DILIDILI
DILI
 
Diabetes presentation nosscr 112011 san antonio 2
Diabetes presentation nosscr 112011 san antonio 2Diabetes presentation nosscr 112011 san antonio 2
Diabetes presentation nosscr 112011 san antonio 2
 
Approach to Recurrent acute pancreatitis
Approach to Recurrent acute pancreatitisApproach to Recurrent acute pancreatitis
Approach to Recurrent acute pancreatitis
 
Common digestive concerns
Common digestive concernsCommon digestive concerns
Common digestive concerns
 
Common liver Disease in Primary Care Setting
Common liver Disease in Primary Care SettingCommon liver Disease in Primary Care Setting
Common liver Disease in Primary Care Setting
 
Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD)
 
Diabetes and gut
Diabetes and gut Diabetes and gut
Diabetes and gut
 
Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019
Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019
Slides From Hot Topics in NASH:New Strategies for the Diagnosis of NASH.2019
 
Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006
 
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity SurgeryResolution of Metabolic Syndrome and Morbid Obesity Surgery
Resolution of Metabolic Syndrome and Morbid Obesity Surgery
 
WWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HSWWDI Clinical Case Study Presentation-HS
WWDI Clinical Case Study Presentation-HS
 
NAFLD
NAFLDNAFLD
NAFLD
 
Chronic hepatitis
Chronic hepatitisChronic hepatitis
Chronic hepatitis
 
Is There a Role for Surgery in the Treatment of Diabetes
Is There a Role for Surgery in the Treatment of DiabetesIs There a Role for Surgery in the Treatment of Diabetes
Is There a Role for Surgery in the Treatment of Diabetes
 
Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...
Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...
Crimson Publishers: Celiac Disease and “Idiopathic” Portal Hypertension: A Ca...
 

Más de Jorge Bustos

Anatomía cardiaca
Anatomía cardiacaAnatomía cardiaca
Anatomía cardiacaJorge Bustos
 
Sepsis, revision de tema dr corzo
Sepsis, revision de tema dr corzoSepsis, revision de tema dr corzo
Sepsis, revision de tema dr corzoJorge Bustos
 
Trombosis venosa profunda
Trombosis venosa profundaTrombosis venosa profunda
Trombosis venosa profundaJorge Bustos
 
Los teléfonos móviles para mejorar la practica de la neurologia
Los teléfonos móviles para mejorar la practica de la neurologiaLos teléfonos móviles para mejorar la practica de la neurologia
Los teléfonos móviles para mejorar la practica de la neurologiaJorge Bustos
 
140 usos de twitter en medicina 2010
140 usos de twitter en medicina 2010140 usos de twitter en medicina 2010
140 usos de twitter en medicina 2010Jorge Bustos
 
Hemorragia intracerebral
Hemorragia intracerebralHemorragia intracerebral
Hemorragia intracerebralJorge Bustos
 

Más de Jorge Bustos (8)

Anatomía cardiaca
Anatomía cardiacaAnatomía cardiaca
Anatomía cardiaca
 
Flipped classroom
Flipped classroomFlipped classroom
Flipped classroom
 
Sepsis, revision de tema dr corzo
Sepsis, revision de tema dr corzoSepsis, revision de tema dr corzo
Sepsis, revision de tema dr corzo
 
Trombosis venosa profunda
Trombosis venosa profundaTrombosis venosa profunda
Trombosis venosa profunda
 
Los teléfonos móviles para mejorar la practica de la neurologia
Los teléfonos móviles para mejorar la practica de la neurologiaLos teléfonos móviles para mejorar la practica de la neurologia
Los teléfonos móviles para mejorar la practica de la neurologia
 
140 usos de twitter en medicina 2010
140 usos de twitter en medicina 2010140 usos de twitter en medicina 2010
140 usos de twitter en medicina 2010
 
Hemorragia intracerebral
Hemorragia intracerebralHemorragia intracerebral
Hemorragia intracerebral
 
Manejo paliativo
Manejo paliativoManejo paliativo
Manejo paliativo
 

Enfermedad del higado graso no alcoholico

  • 1. ENFERMEDAD DEL HIGADO GRASO NO ALCOHOLICO Jorge Arturo Bustos Martinez Residente de segundo año medicina interna Universidad del Norte
  • 2. Definición Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 3. Definición NAFLD termino introducido por primera vez en 1980 por Ludwig Et. Al. clínica Mayo. Tradicionalmente se incluyen dos condiciones distintas: Hígado graso no alcohólico: superior al 5 al 10% del peso total. Esteatohepatitis: esteatosis, inflamación lobular, lesión del hepatocito y/o fibrosis. Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 4. Epidemiologia Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 5. Epidemiologia Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 6. Factores Etiológicos y Asociaciones MarcinKrawczyk Et. Al. Nonalcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 24 (2010) 695–708
  • 7. Factores Etiológicos y Asociaciones Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 8. Factores Etiológicos y Asociaciones Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 9. Factores Etiológicos y Asociaciones Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 10. Factores Etiológicos y Asociaciones John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
  • 11. Fisiopatología Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 12. Fisiopatología Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
  • 13. Fisiopatología John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
  • 14. Fisiopatología Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 15. Fisiopatología John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
  • 16. Fisiopatología John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
  • 17. Fisiopatología Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 18. Diagnostico Mayoría clínicamente asintomáticos: Dolor en cuadrante superior derecho Nauseas Otros síntomas inespecíficos. NASH a Cirrosis: Telangiectasias Eritema palmar Caputmedusae Etc. Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
  • 19. Diagnostico SteatoTest: propuesto por Poynard Et. Al. VPP: 63% VPN: 93% ALT, alfa 2 macroglobulina, Apolipoproteina, Haptoglobina, BT, GGT, Colesterol, Trigliceridos, Glucosa, Edad, Sexo e IMC. FibroTest: Alfa 2 macroglobulina, Apolipoproteina, BT, GGT y ALT. VPP: 73% VPN: 90% Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
  • 20. Diagnostico Jeffrey R. Lewis • Smruti R. Mohanty. Nonalcoholic Fatty Liver Disease: A Review and Update; Dig DisSci (2010) 55:560–578
  • 21. Diagnostico MarcinKrawczyk Et. Al. Nonalcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 24 (2010) 695–708
  • 22. Diagnostico MarcinKrawczyk Et. Al. Nonalcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 24 (2010) 695–708
  • 23. Diagnostico John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104
  • 24. Tratamiento Vassilios A Sevastianos and Stephanos J Hadziyannis.Nonalcoholic fatty liver disease: from clinical recognition to treatment; Expert Rev. Gastroenterol. Hepatol. 2(1), 59–79 (2008)
  • 25. Tratamiento John Edmison, MD, Arthur J. McCullough, MD. Pathogenesis of Non-alcoholic Steatohepatitis: Human Data; Clin Liver Dis 11 (2007) 75–104